Mediclin AG
F:MED
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mediclin AG
F:MED
|
DE |
|
S
|
Syncom Formulations (India) Ltd
NSE:SYNCOMF
|
IN |
|
C
|
Credit Suisse Group AG
XBER:CSX
|
CH |
|
B
|
Bureau Veritas SA
XBER:4BV
|
FR |
|
N
|
Nampak Ltd
JSE:NPK
|
ZA |
|
C
|
Constance Care SA
WSE:CCR
|
PL |
Wall Street
Price Targets
MED Price Targets Summary
Mediclin AG
According to Wall Street analysts, the average 1-year price target for
MED
is 5.8 EUR
with a low forecast of 4.5 EUR and a high forecast of 7.27 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MED's stock price target?
Price Target
5.8
EUR
According to Wall Street analysts, the average 1-year price target for
MED
is 5.8 EUR
with a low forecast of 4.5 EUR and a high forecast of 7.27 EUR.
What is Mediclin AG's Revenue forecast?
Projected CAGR
3%
For the last 13 years the
compound annual growth rate for
Mediclin AG's revenue is
3%.
The projected
CAGR
for the next 3 years is
3%.
What is Mediclin AG's Operating Income forecast?
Projected CAGR
0%
For the last 13 years the
compound annual growth rate for
Mediclin AG's operating income is
14%.
The projected
CAGR
for the next 3 years is
0%.
What is Mediclin AG's Net Income forecast?
Projected CAGR
13%
For the last 13 years the
compound annual growth rate for
Mediclin AG's net income is
18%.
The projected
CAGR
for the next 3 years is
13%.
